About Biopsin
Biopsin is a company based in Singapore (Singapore) founded in 2018 by Amit Kumar and Sheetal Sinha.. Biopsin has raised $175 thousand across 1 funding round from investors including HAX and Entrepreneur First. Biopsin operates in a competitive market with competitors including AFYREN, Spore Biotechnologies, Mesosil, Celsis and Source Molecular, among others.
- Headquarter Singapore, Singapore
- Founders Amit Kumar, Sheetal Sinha
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biopsin Pte Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$175 K (USD)
in 1 rounds
-
Latest Funding Round
$175 K (USD), Seed
Jan 23, 2019
-
Investors
HAX
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biopsin
Biopsin has successfully raised a total of $175K through 1 strategic funding round. The most recent funding activity was a Seed round of $175 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $175,000
-
First Round
First Round
(23 Jan 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Seed - Biopsin | Valuation | HAX , Entrepreneur First |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biopsin
Biopsin has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include HAX and Entrepreneur First. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated via a 111-day program with seed funding.
|
Founded Year | Domain | Location | |
|
Provider of a program turning individuals into funded technology company founders
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biopsin
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biopsin
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biopsin Comparisons
Competitors of Biopsin
Biopsin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Spore Biotechnologies, Mesosil, Celsis and Source Molecular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| domain | founded_year | HQ Location |
Microbial detection technology is developed for life science industries.
|
|
| domain | founded_year | HQ Location |
Antimicrobial materials are developed for infection prevention in medical devices.
|
|
| domain | founded_year | HQ Location |
Rapid microbial screening systems are manufactured for quality control testing.
|
|
| domain | founded_year | HQ Location |
Technology for microbial source tracking is provided by Source Molecular.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biopsin
When was Biopsin founded?
Biopsin was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Biopsin located?
Biopsin is headquartered in Singapore, Singapore.
Who is the current CEO of Biopsin?
Amit Kumar is the current CEO of Biopsin. They have also founded this company.
Is Biopsin a funded company?
Biopsin is a funded company, having raised a total of $175K across 1 funding round to date. The company's 1st funding round was a Seed of $175K, raised on Jan 23, 2019.
What does Biopsin do?
Biopsin was founded in 2018 in Singapore and operates in the biotechnology sector. A microbial detection system is provided for analyzing food, beverages, water, consumer goods, and pharmaceuticals. Pathogenic microbes are extracted and trapped from samples, followed by quantitative analysis at the single-cell level. Operations are focused on real-time testing to ensure product safety across these industries.
Who are the top competitors of Biopsin?
Biopsin's top competitors include AFYREN, Spore Biotechnologies and NCIMB.
Who are Biopsin's investors?
Biopsin has 2 investors. Key investors include HAX, and Entrepreneur First.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.